Hexter Joshua: insider trades.
Hexter Joshua reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($611K), across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 1
- Name as filed
- Hexter Joshua
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Oramed Pharmaceuticals Inc. (ORMP) | Officer · COO & CBO | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-24 | Oramed Pharmaceuticals Inc. | A | 75,455 | — | 1,148,839 | Form 4 |
| 2026-09-24 | Oramed Pharmaceuticals Inc. | A | 209,291 | — | 1,358,130 | Form 4 |
| 2026-07-02 | Oramed Pharmaceuticals Inc. | M | 50,000 | $3.69 | 1,073,384 | Form 4 |
| 2026-07-01 | Oramed Pharmaceuticals Inc. | S | 137,000 | $4.46 | 1,023,384 | Form 4 |
Questions
What stock did Hexter Joshua buy or sell?
Hexter Joshua reported 4 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($611K), across 1 company.
Is Hexter Joshua the same person as other filers with this name?
This page covers SEC CIK 1573235 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/hexter-joshua-1573235.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.